BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18442560)

  • 1. Cellular immunity impaired among patients on left ventricular assist device for 6 months.
    Kimball PM; Flattery M; McDougan F; Kasirajan V
    Ann Thorac Surg; 2008 May; 85(5):1656-61. PubMed ID: 18442560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immunity impaired among patients on left ventricular assist device for 6 months. Invited commentary.
    Conte J
    Ann Thorac Surg; 2008 May; 85(5):1661. PubMed ID: 18442561
    [No Abstract]   [Full Text] [Related]  

  • 3. T-cell response to staphylococcal enterotoxin B is reduced among heart failure patients on ventricular device support.
    Kimball P; Flattery M; Kasirajan V
    Transplant Proc; 2006 Dec; 38(10):3695-6. PubMed ID: 17175370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of endothelial and coagulation systems in left ventricular assist device recipients.
    John R; Panch S; Hrabe J; Wei P; Solovey A; Joyce L; Hebbel R
    Ann Thorac Surg; 2009 Oct; 88(4):1171-9. PubMed ID: 19766802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular assist device-related infection: treatment and outcome.
    Simon D; Fischer S; Grossman A; Downer C; Hota B; Heroux A; Trenholme G
    Clin Infect Dis; 2005 Apr; 40(8):1108-15. PubMed ID: 15791509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
    Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
    J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
    Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
    Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiology of left ventricular assist devices.
    Itescu S; Ankersmit JH; Kocher AA; Schuster MD
    Prog Cardiovasc Dis; 2000; 43(1):67-80. PubMed ID: 10935559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
    Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
    J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function and outcome after continuous flow left ventricular assist device implantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Grimm M; Wolner E; Wieselthaler GM
    Ann Thorac Surg; 2009 Apr; 87(4):1072-8. PubMed ID: 19324130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices.
    Garatti A; Bruschi G; Colombo T; Russo C; Lanfranconi M; Milazzo F; Frigerio M; Vitali E
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):275-80; discussion 280. PubMed ID: 18375138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients.
    Feller ED; Sorensen EN; Haddad M; Pierson RN; Johnson FL; Brown JM; Griffith BP
    Ann Thorac Surg; 2007 Mar; 83(3):1082-8. PubMed ID: 17307463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support.
    Zierer A; Melby SJ; Voeller RK; Guthrie TJ; Ewald GA; Shelton K; Pasque MK; Moon MR; Damiano RJ; Moazami N
    Ann Thorac Surg; 2007 Aug; 84(2):515-20. PubMed ID: 17643627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
    Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device.
    Ankersmit HJ; Tugulea S; Spanier T; Weinberg AD; Artrip JH; Burke EM; Flannery M; Mancini D; Rose EA; Edwards NM; Oz MC; Itescu S
    Lancet; 1999 Aug; 354(9178):550-5. PubMed ID: 10470699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.